Correction: in vitro drug testing using patient-derived ovarian cancer organoids

HIGHLIGHTS

  • Who: from the (UNIVERSITY) have published the research: CORRECTION Open Access, in the Journal: (JOURNAL)

SUMMARY

    Journal of Ovarian Research Open Access CO R R E C T I O N Correction. Paclitaxel and cisplatin x 1 cycle, then gemcitabine and paclitaxel x 3 cycles Paclitaxel and cisplatin x 6 cycles Survival status BRCA Organoid Organoid geme culture expanstatus sion Unex- Success Yes amined Unex- Success amined Unex- Success amined Wild Success type Yes Alive Unex- Success amined Yes Expired Unex- Failed amined Alive Unex- Success amined Yes Expired Yes The original article . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?